Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Rockwell Medical In (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 378,476
  • Shares Outstanding, K 52,060
  • Annual Sales, $ 53,280 K
  • Annual Income, $ -19,800 K
  • 36-Month Beta 2.07
  • Price/Sales 7.08
  • Price/Cash Flow 0.00
  • Price/Book 7.46

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.04 +3.27%
on 07/20/17
8.61 -15.56%
on 06/23/17
-0.92 (-11.23%)
since 06/21/17
3-Month
6.39 +13.77%
on 05/18/17
8.98 -19.04%
on 05/01/17
-0.82 (-10.14%)
since 04/21/17
52-Week
3.55 +104.79%
on 11/08/16
8.98 -19.04%
on 05/01/17
-0.73 (-9.13%)
since 07/21/16

Most Recent Stories

More News
Rockwell Medical Announces Triferic(R) Presentation at Annual Conference on Nephrology & Urology July 6-7th, 2017, Kuala Lumpur, Malaysia

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of...

RMTI : 7.27 (+0.28%)
Rockwell Medical Shareholders Give Mark H. Ravich Sweeping Mandate for Change

--Over 66% of Shares Voted - and More than Half of Rockwell's Outstanding Shares - Were in Support of Ravich

RMTI : 7.27 (+0.28%)
Shareholders Resoundingly Vote to Support Richmond / Ravich Case for Change at Rockwell Medical

Richmond Brothers, Inc., a Michigan-based SEC registered investment advisor and wealth management firm that is the largest beneficial owner of Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell"...

RMTI : 7.27 (+0.28%)
All Three Major Proxy Advisory Firms Recommend Election of Mark H. Ravich to Rockwell Medical Board

--Leading Independent Proxy Firms Endorse Mark H. Ravich for the Rockwell Board

RMTI : 7.27 (+0.28%)
Rockwell Medical Sends Important Message to Richmond Brothers' Clients: You Have the Sole Authority to Vote Your Own Shares

Reminds Shareholders Not to be Misled by Richmond Brothers' Previous Claim to Control 11.8% of Rockwell

RMTI : 7.27 (+0.28%)
Court Denies Rockwell's Motion for Preliminary Injunction against Richmond Brothers and Mark H. Ravich

Richmond Brothers, Inc., a Michigan-based SEC registered investment advisor and wealth management firm that is the largest beneficial owner of Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell"...

RMTI : 7.27 (+0.28%)
Glass Lewis Supports Election of Mark H. Ravich to Rockwell Medical, Inc. Board

--ISS and Glass Lewis Agree that Highly-Qualified Nominee Mark H. Ravich is the Right Choice for the Rockwell Board

RMTI : 7.27 (+0.28%)
Blog Coverage: CHMP Okays French Pharma Major Sanofi's Insulin Lispro Biosimilar for Treatment of Diabetes Mellitus

Upcoming AWS Coverage on Rockwell Medical Post-Earnings Results

RMTI : 7.27 (+0.28%)
SNY : 47.71 (-0.73%)
Rockwell Medical Issues Letter to Shareholders Explaining Why Electing Mark Ravich Could Do Lasting Harm

Rockwell Medical, Inc. (NASDAQ:RMTI) today mailed a letter to its shareholders in connection with the Company's upcoming 2017 Annual Meeting of Shareholders ("Annual Meeting") to be held on June 1, 2017....

RMTI : 7.27 (+0.28%)
ISS Supports Election of Mark H. Ravich to Rockwell Medical, Inc. Board

--ISS Tells Investors that Highly-Qualified Nominee Mark H. Ravich is the Right Choice for the Board

RMTI : 7.27 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Support & Resistance

2nd Resistance Point 7.56
1st Resistance Point 7.42
Last Price 7.27
1st Support Level 7.17
2nd Support Level 7.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.